Is Oral Anticoagulation an Independent Predictor of Mortality in STEMI and High‐Risk NSTEMI Patients After Primary PCI? A Propensity Score‐Matched Retrospective Analysis
Cardiovascular Therapeutics · 2026
DOI: 10.1155/cdr/1295386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2026. Verfasst von Recep Polat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, TC Saglik Bakanligi Dr Siyami Ersek Gogus Kalp ve Damar Cerrahisi Egitim ve Arastirma Hastanesi, İstanbul, Turkey. Hauptthemen laut MEDLINE: Anticoagulants, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction, Non-ST Elevated Myocardial Infarction. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Managing STEMI and high‐risk NSTEMI‐equivalent patients on chronic oral anticoagulation (OAC) undergoing primary PCI poses competing ischaemic and bleeding risks.
Methods
This single‐centre retrospective study enrolled 604 consecutive STEMI/high‐risk NSTEMI patients undergoing primary PCI (2012–2023). OAC users ( n = 100) were compared with propensity score–matched controls ( n = 203). Primary endpoints included all‐cause mortality, bleeding, stroke, recurrent MI and rehospitalisation over a mean 3‐year follow‐up.
Results
OAC users had a higher prevalence of prior ischaemic stroke/TIA (19% vs. 3%, p < 0.001) and known coronary artery disease (33% vs. 20%, p = 0.015). In‐hospital mortality was comparable (7% vs. 5.9%, p = 0.80). Postdischarge long‐term mortality was significantly higher in OAC users (31% vs. 14.8%, p = 0.001), as were access‐site haematoma (8% vs. 2%, p = 0.02) and minor bleeding (7% vs. 1.5%, p = 0.03). On multivariable Cox regression, OAC use was not an independent mortality predictor (HR 0.81, 95% CI 0.47–1.37, p = 0.43); age, reduced ejection fraction and chronic kidney disease were the principal determinants.
Conclusion
Despite higher postdischarge mortality and bleeding, OAC use was not independently associated with mortality after adjustment. Comorbidity burden drives prognosis, emphasising comprehensive risk stratification in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, TC Saglik Bakanligi Dr Siyami Ersek Gogus Kalp ve Damar Cerrahisi Egitim ve Arastirma Hastanesi, İstanbul, Turkey.
- Department of Cardiology, Saglik Bilimleri Universitesi, İstanbul, Turkey.
ORCID-Profile: Recep Polat, Fuat Polat, Yalçın Velibey, Osman Bolca, Göktürk İpek
Zitieren
APA
Polat, R., Polat, F., Velibey, Y., Bolca, O., & İpek, G. (2026). Is Oral Anticoagulation an Independent Predictor of Mortality in STEMI and High‐Risk NSTEMI Patients After Primary PCI? A Propensity Score‐Matched Retrospective Analysis. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/1295386
Vancouver
Polat R, Polat F, Velibey Y, Bolca O, İpek G. Is Oral Anticoagulation an Independent Predictor of Mortality in STEMI and High‐Risk NSTEMI Patients After Primary PCI? A Propensity Score‐Matched Retrospective Analysis. Cardiovascular Therapeutics. 2026. doi:10.1155/cdr/1295386
BibTeX
@article{Polat2026,
author = {Polat, Recep and Polat, Fuat and Velibey, Yalçın and Bolca, Osman and İpek, Göktürk},
title = {Is Oral Anticoagulation an Independent Predictor of Mortality in STEMI and High‐Risk NSTEMI Patients After Primary PCI? A Propensity Score‐Matched Retrospective Analysis},
journal = {Cardiovascular Therapeutics},
year = {2026},
doi = {10.1155/cdr/1295386}
}
EUVIMED